Rhythm Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
/ 
Frequently asked questions
To buy Rhythm Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Rhythm Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Rhythm Pharmaceuticals Inc. is RYTM:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Rhythm Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade Rhythm Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Rhythm Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Rhythm Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Rhythm Pharmaceuticals Inc..